Comprehensive Summary
The study evaluates the effectiveness of Dejal@bot, a conversational AI-powered chatbot, in assisting adults with smoking cessation through a randomized clinical trial conducted in primary care settings. The chatbot provides personalized guidance, behavioral support, and evidence-based interventions to help users quit smoking. By leveraging artificial intelligence, Dejal@bot delivers real-time assistance, monitors progress, and adapts its responses to individual needs. The trial aims to determine the impact of the chatbot on smoking cessation rates compared to traditional interventions, assessing its feasibility, user engagement, and overall effectiveness in primary care settings. The study found that Dejal@bot significantly improved smoking cessation rates, demonstrating the potential of AI-driven tools in promoting smoking cessation by offering scalable, accessible, and cost-effective support. The integration of behavioral science with conversational AI provides continuous motivation and tailored recommendations, potentially improving long-term quit rates.
Outcomes and Implications
Dejal@bot demonstrates the potential of AI-driven tools in promoting smoking cessation by offering scalable, accessible, and cost-effective support. By integrating behavioral science with conversational AI, the chatbot provides continuous motivation and tailored recommendations, potentially improving long-term quit rates. The study’s findings highlight AI’s role in supplementing traditional smoking cessation programs, particularly in primary care settings. However, challenges such as user adherence, digital literacy barriers, and the need for further refinement in chatbot personalization must be addressed to enhance its effectiveness and ensure broad applicability in public health initiatives.